ProjectSupporting a pharma company with the Access to Medicine Index
The access to medicine problem is multifaceted, and responsibility for tackling it lies with many different actors - governments, NGOs, academia, pharmaceutical companies, finance institutions and multilateral organisations such as the WHO. As manufacturers and developers of life-saving products, pharmaceutical companies clearly have a crucial role to play.
Every two years, the Access to Medicine Index independently ranks the 20 largest pharmaceutical companies on their efforts to improve access to medicine in developing countries. The Index publicly recognises companies for their investments in access to medicine, raising awareness of relevant issues within pharmaceutical companies and providing them with a transparent means by which they can assess, monitor and improve their own performance as well as their public and investment profiles.
Endeva supported one of the pharmaceutical companies in its participation in the 2016 Access to Medicines Index through kick-off phase, project management, data collection and data entry.
The outcome was a more detailed and elaborate data submission compared to previous years.